TEAM

Built by people who move science forward.

Decades of AI company-building. Pioneering genomics. Translational medicine. One shared mission: more years of healthy life.

Leadership

Agemica's team combines AI company-building, drug discovery, genomics, peptide biology, and translational medicine to build therapies and vaccines for aging-related disease.

Founder

Prof. Ronjon Nag

Stanford · Cambridge · MIT

40 years building AI companies. Cambridge PhD and MIT MSc. Companies sold to Apple, BlackBerry, and Motorola. IET Mountbatten Medal and Silicon Valley Engineering Hall of Fame.

Read biography

Co-Founder

Dr. Yasaman Kalantar-Motamedi

Cambridge · UCL

Cambridge PhD in AI for drug discovery. UCL MSc in Machine Learning. 12 years of experience connecting computational discovery with experimental validation.

Read biography

Scientific advisor

Prof. Michael Snyder

Stanford genetics · Caltech

Former Chair of Genetics at Stanford, 2009–2024. Director of the Center for Genomics and Personalized Medicine. Co-founder of Personalis (NASDAQ: PSNL). A pioneer in genomics, proteomics, and personal multi-omics, with 1,000+ research papers.

Read biography

Scientific advisor

Dr. Jayakumar Rajadas

Stanford ADDReB

Founding Director of Stanford’s Advanced Drug Delivery and Regenerative Biomaterials Laboratory. Thirty years in drug development. 260+ publications and 82+ patents.

Read biography

Advisor

Anastasiya Giarletta

Principal, R42 Group

AI and longevity investor. Supports the R42 Institute founder ecosystem. Named by Forbes among “8 Female VCs to Look Out For.”